Subscribe to Search results

The Oxford Haemophilia Centre used Profilate and Koate. Dr Rizza described them all as equally effective clinically and they usually use Hemofil.

Published on:

NHS Factor 8 was always in very short supply and reserved as far as possible for young children and adolescents. Dr Rizza wrote that most severely affected patients had changed from NHS to commercial factor VIII, especially those who use larger amounts of factor VIII.

Published on:

A report produced by Dr Rizza held demonstrated how the view of the impact of hepatitis on haemophiliacs changed from the early to late 1970s and how by the late 1970s there were a significant number of people who had significant number with abnormal liver histology consistent with chronic liver disease.

Published on:

A study by J Spero reported persistent abnormalities in liver-function for haemophiliac patients. A significant number demonstrated results of anti-HBc (56 of 65, or 86 percent). Many showed signs of chronic liver disease.

Published on:

Dr Mayne cited a paper by J Spero that structural abnormalities of the liver were described in patients. The paper discusses a study on haemophiliacs deficient in factor VIII or IX where significant numbers showed signs of chronic liver disease.

Published on:

A report by Dr Preston that revealed 77 percent of haemophiliac patients following a systematic screening in Sheffield were revealed to have abnormal liver-function.

Published on:

Dr Preston told the Lindsay Tribunal in 1978 that there was a broad spectrum of chronic liver disease which was both concerning and surprising.

Published on:

After reading the 1978 Sheffield/Preston paper, Dr Colvin accepted that clinicians could no longer work on the assumption that the absence of overt or acute signs was a reliable indicator that a person would not develop NANBH.

Published on:

Oral evidence describes how during the 1970s, Dr Davies had a preference for locally sourced materials due to the risks associated with hepatitis and that novel viruses may be introduced to the local population.

Published on:

Some evidence has held that doctors during the 1970s, 1980s and 1990s were part of a medical regime centred around a more paternalistic paradigm. However, alternate evidence offered to the inquiry have held that regardless of the time period, there are certain fundamental ethical norms and principles which lie at the heart of the medical profession including autonomy, beneficence and non-maleficence.

Published on:

Evidence presented to the inquiry held that while most doctors took the view that not discussing the risks associated with blood products with patients would not result in deterring patients from using the various treatments anyway. However, Professors Farsides and Kerridge on the medical experts panel to the inquiry disagreed, stating until one has disclosed all the risks to a patient, then one cannot assume patients are making a fully informed decision.

Published on:

Speakers from the Medical Ethics Experts Panel held that it was ethically wrong not to explain the risks of treatment to patients.

Published on:

Speakers from the Medical Ethics Experts Panel held that it was ethically wrong not to promptly provide patients with the outcomes of their diagnosis and test results.

Published on:

In Edinburgh the principal product used in 1976 was cryoprecipitate.

Published on:

In Edinburgh the principal product used in 1977 was cryoprecipitate.

Published on:

In Edinburgh the principal product used in 1978 was cryoprecipitate.

Published on:

In Edinburgh the principal product used in 1979 was cryoprecipitate.

Published on:

From 1980, when Professor Ludlam arrived in Edinburgh, the volume of NHS concentrates used exceeded the volume of cryoprecipitate for the first time.

Published on:

In 1974 - 1975, at the Glasgow Royal Infirmary while commercial concentrates were in use cryoprecipitate was the predominant product.

Published on:

During the 1980, the haemophilia centre at the Royal Hospital for Sick Children ("RHSC") in Yorkhill, Glasgow, provided haemophilia treatment to children from the Glasgow area and across the West of Scotland. 55 had Haemophilia A, 14 had Haemophilia B and 1 had von Willebrand disease.

Published on: